Anais Debesset et al.
TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion
Journal for ImmunoTherapy of Cancer 2024, vol. 12, issue 11
doi: 10.1136/jitc-2024-008898